Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

HeartSciences Q1 EPS $(1.58) Beats $(2.09) Estimate, Sales $1.900M

Author: Benzinga Newsdesk | September 11, 2025 03:24pm

HeartSciences Inc. (NASDAQ:HSCS) reported quarterly losses of $(1.58) per share which beat the analyst consensus estimate of $(2.09) by 24.4 percent. This is a 40.15 percent increase over losses of $(2.64) per share from the same period last year. The company reported $1.900 million in sales this quarter.

Posted In: HSCS


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist